Kevin Myant

Dr. Kevin Myant is a CRUK Career Development Fellow and Principal Investigator at the MRC Institute of Genetics & Molecular Medicine, University of Edinburgh. His research focuses on colorectal stem cell transformation, RNA splicing dysregulation, and tumourigenesis mechanisms.

• Education: Not explicitly mentioned in the text

Research Interests: His lab investigates how alternative RNA splicing drives colorectal cancer development, with a focus on Rac1 hyperactivation, hybrid-EMT regulation, and therapeutic vulnerabilities. Collaborations include institutions in Glasgow, London, and Royal Holloway.

Scientific Contributions: Recent work includes identifying DOCK2 loss as a driver of IBD-associated colorectal cancer and elucidating splicing factor roles in tumor plasticity. Publications span Nature, Gut, and Oncogene.

• Scientific Awards:
  • CRUK Career Development Fellowship
  • ISSF2 Strategic Award

Current Projects: Funded by Cancer Research UK, Medical Research Council, and Boehringer Ingelheim, including "Development of novel polyp prevention strategies in Familial Adenomatous Polyposis" and "Immunotherapeutic enhancement through inhibition of alternative splicing."